Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2007 > November > 6 > Statins After Bypass Lower Stroke Risk
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

Statins After Bypass Lower Stroke Risk

TUESDAY, Nov. 6 (HealthDay News) -- Treatment with cholesterol-lowering statin drugs after coronary artery bypass graft (CABG) surgery reduces a patient''s risk of stroke, U.S. researchers report.

The study, from the Cleveland Clinic, included more than 5,200 patients who underwent bypass between early 1993 and late 2005. The overall incidence of post-operative stroke one year after surgery was 3.3 percent (181 strokes).

"Patients discharged on statin therapy were more likely to have a lower low-density cholesterol (LDL or "bad" cholesterol) and were significantly less likely to suffer a post-operative stroke at one year," the researchers wrote.

They also said that age, peripheral vascular disease and kidney disease were independent predictors of stroke, heart attack or death. The use of both statin and ACE inhibitors significantly reduced risk, they found.

"These data suggest that a discharge regimen including statin therapy may reduce post-operative morbidity and warrants prospective validation," the researchers concluded.

The study was to be presented Tuesday at the American Heart Association annual meeting, in Orlando, Fla.

More information

The Society of Thoracic Surgeons has more about CABG.



-- Robert Preidt



SOURCE: Nov. 6, 2007, presentation, American Heart Association annual meeting, Orlando, Fla.

Last Updated: Nov. 06, 2007

Copyright © 2007 ScoutNews, LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement